M1 Kliniken AG

First Mover in the billion euro market

Aesthetic treatments have become an accepted part of society, growing into a billion dollar market... 
M1 Kliniken AG

First Mover in the billion euro market

...Demand is rising and offers M1 sustainable growth potential.

Succeeding with world-class medicine

M1 Kliniken AG

Medical Care For a Better Life – with this vision M1 Kliniken AG, one of the fastest growing healthcare services providers in Germany, has developed an innovative concept, which offers affordable access to beauty treatments at highest qualitative standards.

Investor Relations M1 Kliniken AG

M1 stock

ISIN: DE000A0STSQ8 | WKN: A0STSQ | Ticker symbol: M12

Title name: Bearer Share
Number of shares: 18,555,114
Stock exchange: Frankfurt, Stuttgart, Berlin, Düsseldorf, München, Hannover, Xetra, Hamburg, Tradegate Exchange
Market segment: Open Market
Designated Sponsoring: mwb fairtrade
Inital trading day: 14.09.2015

More information

| Investor News

M1 Kliniken AG (ISIN DE000A0STSQ8) has cancelled the treasury shares acquired under its share buyback programme and reduced its share capital accordingly.

On 25 March 2026, the Management Board resolved, with the approval of the Supervisory Board granted on 26 March 2026 and on the basis of the authorisation by the Annual General Meeting of 17 July 2024, to reduce the Company's share capital by EUR 1,088,289 from EUR 19,643,403 to EUR 18,555,114. The capital reduction became effective upon registration in the commercial register of the Local Court of Charlottenburg (HRB 107637 B) on 26 May 2026.

| Investor News

Group key figures at a glance

  • Group revenue: +7.4% to EUR 364.3 million (FY 2024: EUR 339.2 million)
  • EBITDA: +23.6% to EUR 39.4 million (FY 2024: EUR 31.9 million)
  • EBIT: +29.2% to EUR 34.6 million (FY 2024: EUR 26.8 million)
  • EBIT margin: 9.5% (FY 2024: 7.9%)
  • EBT: +29.5% to EUR 34.1 million (FY 2024: EUR 26.3 million)
  • Earnings per share: EUR 1.19 (FY 2024: EUR 0.85)

| Investor News

  • Group revenue: +7.4% to EUR 364.3 million (FY 2024: EUR 339.2 million)
  • EBITDA: +23.6% to EUR 39.4 million (FY 2024: EUR 31.9 million)
  • EBIT: +29.2% to EUR 34.6 million (FY 2024: EUR 26.8 million)
  • EBIT margin: 9.5% (FY 2024: 7.9%)
  • EBT: +29.5% to EUR 34.1 million (FY 2024: EUR 26.3 million)
  • Earnings per share: EUR 1.19 (FY 2024: EUR 0.85)

Contact

M1 Kliniken AG

Grünauer Straße 5
12557 Berlin
Germany

T. +49 (0) 30 347 47 44 14

Contact us